Vasoactive Intestinal Peptide as a Diagnostic or Prognostic Biomarker in Multiple Sclerosis: a Systematic Review Protocol

Protocol for a systematic review entitled 'Vasoactive Intestinal Peptide as a Diagnostic or Prognostic Biomarker in Multiple Sclerosis: a Systematic Review'.

Authors

Institutions

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-01-13
DOI
https://doi.org/10.5281/zenodo.18228723
Primary Topic
S100 Proteins and Annexins
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Vasoactive Intestinal Peptide as a Diagnostic or Prognostic Biomarker in Multiple Sclerosis: a Systematic Review Protocol

Yasmina Juarranz, Mª del Carmen Martínez, Alicia Cabrera Martín, Irene Gutiérrez-Cañas
Zenodo (CERN European Organization for Nuclear Research)
S100 Proteins and Annexins
article

Vasoactive Intestinal Peptide as a Diagnostic or Prognostic Biomarker in Multiple Sclerosis: a Systematic Review Protocol

Yasmina Juarranz, Mª del Carmen Martínez, Alicia Cabrera Martín, Irene Gutiérrez-Cañas
article en

Abstract

Protocol for a systematic review entitled 'Vasoactive Intestinal Peptide as a Diagnostic or Prognostic Biomarker in Multiple Sclerosis: a Systematic Review'.

Zenodo (CERN European Organization for Nuclear Research)
Universidad Complutense de Madrid (ES)
Good health and well-being
Openalex Percentile: Top 89%
S100 Proteins and Annexins
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Vasoactive Intestinal Peptide as a Diagnostic or Prognostic Biomarker in Multiple Sclerosis: a Systematic Review Protocol — Yasmina Juarranz, Mª del Carmen Martínez, et al. · Zenodo (CERN European Organization for Nuclear Research) (2026) | TGRS Research Map | TGRS